Fayez Sarofim & Co’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$819K Hold
10,477
﹤0.01% 200
2025
Q1
$759K Sell
10,477
-3,278
-24% -$238K ﹤0.01% 205
2024
Q4
$1.02M Sell
13,755
-210
-2% -$15.5K ﹤0.01% 185
2024
Q3
$922K Hold
13,965
﹤0.01% 179
2024
Q2
$1.29M Hold
13,965
﹤0.01% 159
2024
Q1
$1.33M Hold
13,965
﹤0.01% 156
2023
Q4
$1.19M Sell
13,965
-1,598
-10% -$136K ﹤0.01% 156
2023
Q3
$1.08M Sell
15,563
-2,500
-14% -$173K ﹤0.01% 165
2023
Q2
$1.7M Sell
18,063
-705
-4% -$66.5K 0.01% 149
2023
Q1
$1.55M Sell
18,768
-105
-0.6% -$8.69K 0.01% 159
2022
Q4
$1.41M Hold
18,873
0.01% 155
2022
Q3
$1.56M Hold
18,873
0.01% 154
2022
Q2
$1.8M Sell
18,873
-460
-2% -$43.8K 0.01% 150
2022
Q1
$2.28M Hold
19,333
0.01% 150
2021
Q4
$2.51M Sell
19,333
-643
-3% -$83.3K 0.01% 152
2021
Q3
$2.26M Hold
19,976
0.01% 148
2021
Q2
$2.07M Sell
19,976
-3,560
-15% -$369K 0.01% 157
2021
Q1
$1.97M Buy
23,536
+3,430
+17% +$287K 0.01% 143
2020
Q4
$1.83M Hold
20,106
0.01% 144
2020
Q3
$1.61M Buy
20,106
+422
+2% +$33.7K 0.01% 143
2020
Q2
$1.36M Buy
19,684
+2,578
+15% +$178K 0.01% 145
2020
Q1
$1.08M Hold
17,106
0.01% 145
2019
Q4
$1.33M Buy
17,106
+3,729
+28% +$290K 0.01% 152
2019
Q3
$981K Buy
13,377
+3,627
+37% +$266K 0.01% 163
2019
Q2
$600K Buy
9,750
+570
+6% +$35.1K ﹤0.01% 179
2019
Q1
$585K Buy
9,180
+420
+5% +$26.8K ﹤0.01% 177
2018
Q4
$447K Sell
8,760
-420
-5% -$21.4K ﹤0.01% 185
2018
Q3
$533K Hold
9,180
﹤0.01% 182
2018
Q2
$445K Buy
+9,180
New +$445K ﹤0.01% 191